Mixed connective tissue disease epidemiology and demographics: Difference between revisions
Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of mixed connective tissue disease is approximately 2.7 per 100,000 individuals per year.<ref name="pmid24353496">{{cite journal |vauthors=Latuśkiewicz-Potemska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E |title=Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl |journal=Postepy Dermatol Alergol |volume=30 |issue=5 |pages=329–36 |date=October 2013 |pmid=24353496 |pmc=3858664 |doi=10.5114/pdia.2013.38365 |url=}}</ref> | *The [[Incidence (epidemiology)|incidence]] of mixed connective tissue disease is approximately 2.7 per 100,000 individuals per year.<ref name="pmid24353496">{{cite journal |vauthors=Latuśkiewicz-Potemska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E |title=Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl |journal=Postepy Dermatol Alergol |volume=30 |issue=5 |pages=329–36 |date=October 2013 |pmid=24353496 |pmc=3858664 |doi=10.5114/pdia.2013.38365 |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
Line 14: | Line 14: | ||
===Mortality rate=== | ===Mortality rate=== | ||
*In MCTD, the mortality rate is nearly 10.4% over the period of 13-15 years.<ref name="pmid24433611">{{cite journal |vauthors=Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA |title=Cardiac involvement in mixed connective tissue disease: a systematic review |journal=Int. J. Cardiol. |volume=171 |issue=3 |pages=326–30 |date=February 2014 |pmid=24433611 |doi=10.1016/j.ijcard.2013.12.079 |url=}}</ref> | *In MCTD, the [[mortality rate]] is nearly 10.4% over the period of 13-15 years.<ref name="pmid24433611">{{cite journal |vauthors=Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA |title=Cardiac involvement in mixed connective tissue disease: a systematic review |journal=Int. J. Cardiol. |volume=171 |issue=3 |pages=326–30 |date=February 2014 |pmid=24433611 |doi=10.1016/j.ijcard.2013.12.079 |url=}}</ref> | ||
===Age=== | ===Age=== |
Revision as of 14:13, 12 April 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease epidemiology and demographics |
FDA on Mixed connective tissue disease epidemiology and demographics |
on Mixed connective tissue disease epidemiology and demographics |
Mixed connective tissue disease epidemiology and demographics in the news |
Blogs onMixed connective tissue disease epidemiology and demographics |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of mixed connective tissue disease is approximately 2.7 per 100,000 individuals per year.[1]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Mortality rate
- In MCTD, the mortality rate is nearly 10.4% over the period of 13-15 years.[2]
Age
- Mixed connective tissue disease is usually diagnosed during childhood. It usually starts between 2 and 16 years of age (mean age of 11 years old).[1]
Race
- MCTD is more frequent in the black population and among Asians.[3]
Gender
- Female are more commonly affected by mixed connective tissue disease than male. The female to male ratio is approximately 10 to 1.[4]
References
- ↑ 1.0 1.1 Latuśkiewicz-Potemska J, Zygmunt A, Biernacka-Zielińska M, Stańczyk J, Smolewska E (October 2013). "Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl". Postepy Dermatol Alergol. 30 (5): 329–36. doi:10.5114/pdia.2013.38365. PMC 3858664. PMID 24353496.
- ↑ Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA (February 2014). "Cardiac involvement in mixed connective tissue disease: a systematic review". Int. J. Cardiol. 171 (3): 326–30. doi:10.1016/j.ijcard.2013.12.079. PMID 24433611.
- ↑ Missounga L, Ba JI, Nseng Nseng Ondo IR, Nziengui Madjinou M, Malekou D, Mouendou Mouloungui EG, Nzengue EE, Boguikouma JB, Kombila M (2017). "[Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature]". Pan Afr Med J (in French). 27: 162. doi:10.11604/pamj.2017.27.162.12572. PMC 5567953. PMID 28904690. Vancouver style error: initials (help)
- ↑ Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL (December 2016). "Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study". Arthritis Care Res (Hoboken). 68 (12): 1843–1848. doi:10.1002/acr.22872. PMC 5426802. PMID 26946215.